69 Patient subsets with T1-2, node-negative breast cancer at high locoregional recurrent risks after mastectomy
Radiotherapy and Oncology. 2004;72:S22 
298Survival following locoregional recurrent breast cancer — results from a prospective study with more than 10 years of follow-up
Radiotherapy and Oncology. 1996;40:S78
50 Intraoperative brachytherapy in recurrent breast carcinoma
Radiotherapy and Oncology. 1994;31:S34
SP-0476: Personalised local and locoregional radiotherapy in breast cancer
Radiotherapy and Oncology. 2017;123:S253
SP-0456: Locoregional management for triple negative breast cancer
Radiotherapy and Oncology. 2014;111:S180
429 Poster Radiotherapy as the primary locoregional treatment for breast cancer clinical stage III A
Radiotherapy and Oncology. 2002;64:S141
Changes in pulmonary function tests in breast carcinoma patients treated with locoregional post-mastectomy radiotherapy: results of a pilot study
Breast Cancer: Targets and Therapy. 2017;Volume 9:375-381
PG 10.02 Evolving standards in breast cancer radiotherapy: who should receive locoregional RT?
The Breast. 2015;24:S19-S20
Hyperthermia with low-dose radiotherapy for recurrent breast carcinoma
The Lancet. 1991;337(8732):59
96 Set up deviations in locoregional radiotherapy for breast cancer using an offline electronic portal imaging protocol
Radiotherapy and Oncology. 2002;65:S23